MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

VItamin D Effect on Osteoarthritis Study

Phase 3
Completed
Conditions
Osteoarthritis, Knee
Interventions
Drug: Placebo
Drug: Vitamin D
First Posted Date
2010-08-06
Last Posted Date
2015-09-09
Lead Sponsor
Menzies Institute for Medical Research
Target Recruit Count
413
Registration Number
NCT01176344
Locations
🇦🇺

Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia

🇦🇺

Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Victoria, Australia

Impact of Vitamin D Repletion in Hemodialysis Patients

Not Applicable
Completed
Conditions
Vitamin D Deficiency
End-stage Renal Disease
Interventions
First Posted Date
2010-08-05
Last Posted Date
2014-09-22
Lead Sponsor
Mehrotra, Anita, M.D.
Target Recruit Count
116
Registration Number
NCT01175798
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients

Phase 3
Terminated
Conditions
Chronic Kidney Disease Stage 3 and 4
Interventions
First Posted Date
2010-08-02
Last Posted Date
2017-04-04
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
19
Registration Number
NCT01173848
Locations
🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals

Phase 3
Terminated
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Placebo
Drug: Vitamin D3
First Posted Date
2010-07-27
Last Posted Date
2018-03-07
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
25
Registration Number
NCT01170468
Locations
🇸🇦

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2010-07-21
Last Posted Date
2016-07-18
Lead Sponsor
Carol Fabian, MD
Target Recruit Count
30
Registration Number
NCT01166763
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Effect of Vitamin D Replacement During Winter Months in Patients With Hypertension

Phase 2
Completed
Conditions
Hypertension
Vitamin D Deficiency
Interventions
First Posted Date
2010-07-20
Last Posted Date
2012-06-19
Lead Sponsor
Regional Hospital Holstebro
Target Recruit Count
136
Registration Number
NCT01166165
Locations
🇩🇰

Department of Medical Research, Holstebro, Denmark

High Dose Vitamin D Study

Phase 1
Completed
Conditions
Colorectal Cancer
Interventions
First Posted Date
2010-06-25
Last Posted Date
2017-03-03
Lead Sponsor
University of British Columbia
Target Recruit Count
40
Registration Number
NCT01150877
Locations
🇨🇦

InspireHealth, Vancouver, British Columbia, Canada

Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption

Not Applicable
Completed
Conditions
Chronic Pancreatitis
Malabsorption Syndromes
Interventions
Drug: Calcium, Dietary
Radiation: UV-filtered light.
Drug: Cholecalciferol
Radiation: UVB
First Posted Date
2010-06-11
Last Posted Date
2011-12-23
Lead Sponsor
Hvidovre University Hospital
Target Recruit Count
27
Registration Number
NCT01141998
Locations
🇩🇰

Hvidovre Hospital, Hvidovre, Denmark

Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery

Phase 3
Completed
Conditions
Gastric Bypass
Parathyroid Hormone
Interventions
First Posted Date
2010-06-07
Last Posted Date
2017-03-22
Lead Sponsor
Kerstyn C. Zalesin, M.D.
Target Recruit Count
49
Registration Number
NCT01138475
Locations
🇺🇸

William Beaumont Health Center, Royal Oak, Michigan, United States

Replacement of Vitamin D in Patients With Active Tuberculosis

Not Applicable
Completed
Conditions
Tuberculosis, Pulmonary
Interventions
Drug: Cholecalciferol
Drug: Saline injection
First Posted Date
2010-05-26
Last Posted Date
2011-06-28
Lead Sponsor
Aga Khan University
Target Recruit Count
259
Registration Number
NCT01130311
Locations
🇵🇰

Ojha Istitute of Chest Diseases, Karachi, Sind, Pakistan

🇵🇰

Aga Khan University, Karachi, Sind, Pakistan

🇵🇰

Abbasi Shaheed Hospital, Karachi, Sind, Pakistan

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath